Schutte John 13D/13G Filings for Acura Pharmaceuticals, Inc. (ACUR)

Schutte John 13D and 13G filings for Acura Pharmaceuticals, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2021-06-28
11:17 am
Purchase
2021-06-09 13D Acura Pharmaceuticals, Inc.
ACUR
Schutte John 52,984,375
70.600%
5,484,375increase
(+11.55%)
Filing